The company’s bronchoscopes can be used in endoscopic diagnosis. Credit: sfam_photo / Shutterstock.com.

Olympus Corporation of the Americas (Olympus) has issued a voluntary labelling update for bronchoscopes used with laser therapy equipment.

The voluntary field corrective action is intended to address complaints of endobronchial combustion occurring while using laser-compatible bronchoscopes at the time of therapeutic procedures along with argon plasma coagulation (APC) or laser therapy equipment.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The corporation has included 32 BF series endoscope models in this global action, with 19 of these models being supplied in the US.

Olympus has notified this action to the US Food and Drug Administration and other regulatory bodies.

The company’s bronchoscopes are suitable for use in endoscopic diagnosis and treatment within the airways and the tracheobronchial tree.

See Also:

It evaluated the issue after receiving adverse event complaints, including one death and patient injury.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The corporation also determined that updated labelling was required to specify laser compatibility and warn about the risks associated with incompatible laser use as well as bolster existing warnings.

Olympus received a complaint about endobronchial combustion with APC but the cause related to the event could not be determined. It is also not implementing any updates to the labelling regarding the use of APC.

The company did not assess any other lasers for compatibility with the indicated bronchoscope models.

In addition, the corporation suggests that users must carefully study warnings in the operation manual on laser cauterisation with its bronchoscopes.